PBK and breast neoplasm: Therefore, PBK is also a potential therapeutic target, as it encodes a mitotic protein, member of MAPK kinases family, which was found to be over-expressed in haematological (Nandi et al, 2004) and breast tumours (Park et al, 2006), and in PDTC cell lines (Rodrigues et al, 2007).